Celastrol Mediated Regulation of the HnRNPA1 ‐Thyroxine Axis in the Amygdala Alleviates High Fat Diet‐Induced Demyelination and Cognitive Deficits in Mice
Phytotherapy Research · 2025
DOI: 10.1002/ptr.8520 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2025. Verfasst von Xuemin Yao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Pentacyclic Triterpenes, Heterogeneous Nuclear Ribonucleoprotein A1, Cognitive Dysfunction, Amygdala. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Public Welfare Research Institutes, China Academy of Chinese Medical Sciences, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
High fat diet (HFD) is closely linked to demyelination and cognitive deficiency. Previously, we reported that the covalent binding and downregulation of heterogeneous nuclear ribonucleoprotein A1 (HnRNPA1) were responsible for the effectiveness of celastrol against high fat diet (HFD) induced obesity. However, little is known about cognitive functions. This study aimed to evaluate the effectiveness and mechanism of celastrol on cognitive functions and demyelination in HFD mice. In HFD mice, the anti‐cognitive dysfunction and anti‐demyelination effects of celastrol and HnRNPA1‐shRNA were evaluated by Morris water maze and luxol‐fast‐blue staining. Then, the common biological pathway of celastrol and HnRNPA1‐shRNA was clarified by the transcriptomic and metabolomic analyses of amygdala tissue and verified in the amygdala and in cultured MO3.13 cells. Celastrol and HnRNPA1‐shRNA alleviated cognitive impairments and amygdala demyelination in HFD mice. By transcriptome analysis, genes co‐regulated by celastrol and HnRNPA1‐shRNA were focused on the myelin generating cells‐oligodendrocyte. Celastrol and HnRNPA1‐shRNA alleviated oligodendrocyte differentiation disorder and myelin loss induced by HFD. Association analysis of metabolome and transcriptome indicated that the enhanced central transport and inhibited inactivation of thyroxine may underlie celastrol and HnRNPA1‐shRNA mediated regulation of oligodendrocyte. In MO3.13 cells, celastrol mediated downregulation of HnRNPA1. In addition, the pro‐maturation effects of celastrol and HnRNPA1‐shRNA were confirmed by the downregulation of Dio3 and O1, as well as the upregulation of MBP. Through HnRNPA1‐thyroxine axis, celastrol protects against HFD‐induced demyelination and cognitive deficits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
- Artemisinin Center, China Academy of Chinese Medical Sciences, Beijing, China.
ORCID-Profile: Na Lin
Förderung
- Fundamental Research Funds for the Central Public Welfare Research Institutes
- China Academy of Chinese Medical Sciences
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Yao, X., Zhang, S., Zhang, G., Liu, Y., Zhu, Y., Wang, W., Zhu, C., & Lin, N. (2025). Celastrol Mediated Regulation of the HnRNPA1 ‐Thyroxine Axis in the Amygdala Alleviates High Fat Diet‐Induced Demyelination and Cognitive Deficits in Mice. Phytotherapy Research. https://doi.org/10.1002/ptr.8520
Vancouver
Yao X, Zhang S, Zhang G, Liu Y, Zhu Y, Wang W, et al. Celastrol Mediated Regulation of the HnRNPA1 ‐Thyroxine Axis in the Amygdala Alleviates High Fat Diet‐Induced Demyelination and Cognitive Deficits in Mice. Phytotherapy Research. 2025. doi:10.1002/ptr.8520
BibTeX
@article{Yao2025,
author = {Yao, Xuemin and Zhang, Shuangpan and Zhang, Guoxin and Liu, Ying and Zhu, Yongping and Wang, Wenli and Zhu, Chunyan and Lin, Na},
title = {Celastrol Mediated Regulation of the HnRNPA1 ‐Thyroxine Axis in the Amygdala Alleviates High Fat Diet‐Induced Demyelination and Cognitive Deficits in Mice},
journal = {Phytotherapy Research},
year = {2025},
doi = {10.1002/ptr.8520}
}
EUVIMED